Skip to NavigationSkip to content

News

Bristol-Myers Squibb has agreed to sell off Celgene’s psoriasis treatment Otezla, to appease antitrust regulators.
Pfizer’s Talzenna (talazoparib) has secured approval in Europe from the European Commission, the drugmaker has confirmed, as a monotherapy for the...
Indian firm Glenmark Pharmaceuticals has entered into an agreement with Novartis over the distribution of its respiratory products in Brazil.
Vertex has announced that the FDA has chosen to expand the existing authorisation on its cystic fibrosis (CF) therapy Symdeko.
The FDA has approved AMAG Pharmaceuticals’ bremelanotide – sold under the brand name Vyleesi – for premenopausal women with generalised hypoactive...
A third (33%) of brits stockpile medicines, according to new research from Co-op Health.
Drugmakers sue Trump over pricing ads, more warnings over the impact of a no-deal Brexit on medicines access and pricing, and scientists uncover the...
The European Commission has awarded approval to Novo Nordisk’s extended half-life factor VIII therapy Esperoct (turoctocog alfa pegol, N8-GP) for...
Sanofi has announced that plans to reorganise its research and development operations will result in the losses of 466 jobs across Germany and...
The European Commission has said that GlaxoSmithKline has offered concessions to address concerns relating to the British multinational’s planned...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches